• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, July 4 Drug-maker USV Ltd’s manufacturing facility at Daman that makes finished dosage forms of medicines has received approval from the United States Food and Drug Administration. This will allow the company to manufacture medicines at the plant and export it to the US.

The company has filed four Abbreviated New Drug Applications in the US through Indicus Pharma LLc, its affiliate company, a USV note said. The Daman facility was earlier approved by the National Agency for Medicines, Finland for supplies to the European Union.

USV focuses on the lifestyle therapeutic segment. The company has a USFDA and TGA approved bulk-drug facility at Chiplun, as well. The Rs 670-crore Mumbai-based USV is the world’s largest manufacturer of Metformin, used in anti-diabetic drugs.

Mr Prashant Tewari, Managing Director of USV Ltd said the company was already exporting bulk drugs to the US and the approval for the formulations or finished dosage forms facility would boost USV’s plans for the US.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
USV gets USFDA nod for Daman facility

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line